News
Identified a key molecular pathway in the acquisition of resistance to therapy in certain breast tumors
Estrogens are essential female hormones that perform many basic functions in the body. However, on some occasions it may also cause or contribute to the growth of some cancers, including breast, because it stimulates the growth and division of tumor cells. The estrogens-responsive tumors are known as “positive for the estrogens receptor” and it is […]
Discovered a new way to control genetic material altered in cancer
When we talk about genetic material, we are usually referring to the DNA (deoxyribonucleic acid) that we inherit from our parents. This DNA is the factory where is built a similar molecule called RNA (ribonucleic acid) which produces our proteins, such as hemoglobin or insulin , allowing the lives of our cells. But there is […]
Manel Esteller, elected Member of Editorial Board of Genome Research
Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and Professor of Genetics at the University of Barcelona, has been appointed Member of the Editorial Board of Genome Research. The journal publishes outstanding original research worldwide since 1995 and is recognized internationally as the most current […]
Identified a hundred biomarkers, useful to predict the evolution of colorectal cancer
The tumor microenvironment New biomarkers Article reference Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic
Students of the High School Provençana visit IDIBELL research support platforms
On Tuesday May 6 students of higher technical certificate in Lab of analysis and quality of Provençana Institute of Hospitalet de Llobregat visited the IDIBELL to learn about how research is done. Students had the opportunity to know how some IDIBELL research support platforms work. Specifically, they visited units of proteomics and genomics. This initiative […]
Identified two new genes involved in the more aggressive prostate cancer
The study opens the door to distinguish patients who will suffer particularly virulent prostate tumors to personalize treatment Prostate cancer Identify high-risk patients Two new genes in the spotlight
Manel Esteller, awarded the Prize of Honor Dr. Benaprès 2014
The Director of Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research and Professor at the University of Barcelona, Manel Esteller, earned the Award of Honor Dr. Benaprès 2014 for his scientific career, awarded by the Spanish Society of Cosmetic Medicine and Surgery. The award is given for the multiple […]
IDIBELL prepares the Human Resources Strategy for Researchers 2014-2017
The European Commission has adopted the “European Charter for Researchers” and the “Code of Conduct for the Recruitment of Researchers” as key elements to encourage the mobility of researchers and the harmonization of their work conditions across Europe. IDIBELL endorsed the principles outlined by these two documents on August 1st 2013. Some of the highlights […]